About Travis Wager
Travis Wager is co-founder, president and chief scientific officer of Rgenta Therapeutics. The company develops RNA-targeting medicines for diseases that other treatments cannot reach, including cancers and neurological disorders. Wager co-founded Rgenta in 2020 and has served as its chief scientific officer since then.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Travis Wager in the role, so the role may have started earlier or lasted longer.
Rgenta Therapeutics, Inc. Current
Co-founder, President and CSO
2020 – Present · Woburn, MA
The company develops oral small-molecule drugs that target RNA to treat cancer and neurological diseases that current medicines cannot reach.
Key Colleagues at Startups
The people Travis Wager works with at each company, as listed on that company's latest Form D.
Rgenta Therapeutics, Inc. · Form D, Nov 3, 2026
HX
Hualin Xi
Co-founder and CEO, director
YF
Yichao Fan
Director
Debasish Roychowdhury
Director
Julia Kaufman
Director
SZ
Sean Zhang
Director and promoter
CK
Cillian King
Director and promoter
JK
James Kasuboski
Director
ZW
Zhiping Weng
Director
Jeff Guckert
Director of Finance
Sources
- SECRgenta Therapeutics, Inc. Form D, filed Nov 3, 2026
- press_releaseRgenta Therapeutics Launches with $20 Million Seed Investment
- press_releaseRgenta Therapeutics Enters into a Collaboration with Lundbeck
- press_releaseRgenta Therapeutics to Present at the 19th Annual Huntington's Disease Therapeutics Conference